The Hematologist COVID-19 Resources
The Hematologist is dedicated to covering important topics at the intersection of hematology and COVID-19 treatment. Please browse the available articles and podcasts below.
COVID-19 Articles from The Hematologist
Please find the latest COVID-19 research articles published in The Hematologist. All articles in this collection are freely available to read.
Hematologic Therapies Being Studied for Coronavirus: Capitalizing on Progress
Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place?
ASH Members Respond to COVID-19 Challenges
President's Column: The New Normal
Image Challenge: Spots and Dots
#ASH20: An Unconventionally Conventional Meeting
2020 ASH News Daily Editor Dr. Ahmar Zaidi provides a wrap-up of the 2020 ASH Annual Meeting.
Are Patients With Blood Cancers at a Higher Risk of COVID-19 Infection?
Being ASH President During a Pandemic
ASH President Dr. Stephanie Lee reflects on her ASH presidency during a tumultuous year.
Complement and Thrombosis: What Is, and What Might Be
Dr. Eric Tseng discusses a broader understanding of how the complement and coagulation systems are intertwined.
Convalescent Plasma for COVID-19: An Old Therapy for a Novel Pathogen
How COVID-19 Has Changed ASH Advocacy
In Anticipation of the Wave
My Poor Self-Care During the Pandemic
In his inaugural President’s Column, 2021 ASH President Dr. Martin S. Tallman ushers in a new year for ASH.
Practical Issues in Lymphoma Care During the COVID-19 Pandemic
Drs. Lisa Hicks and Abi Vijenthira discuss the impact of COVID-19 on lymphoma care.
COVID-19: ASH’s Response Draws on the Strength of Our Community
Rethinking Our Work
Rethinking Professional Meetings for the Virtual Era
Editor-in-Chief Dr. Laura Michaelis discusses virtual scientific meetings and looks forward to the 2020 ASH Annual Meeting.
The Challenge We Face: Sickle Cell Disease and the COVID-19 Pandemic
The COVID Coagulopathy Conundrum: Facts, Fiction, and Fantasy
Things Done Right in 2020
Editor-in-Chief Dr. Laura Michaelis discusses successes of ASH and the hematology community amidst COVID-19.